- Report
- February 2025
- 200 Pages
Global
From €4096EUR$4,490USD£3,523GBP
- Report
- July 2024
- 150 Pages
Global
From €3421EUR$3,750USD£2,942GBP
- Report
- October 2024
- 93 Pages
Global
From €3500EUR$4,110USD£3,115GBP
- Report
- April 2025
- 50 Pages
Global
From €2418EUR$2,650USD£2,079GBP
Nicotine Polacrilex is a type of Over the Counter (OTC) drug used to help people quit smoking. It is a form of nicotine replacement therapy (NRT) that works by releasing small amounts of nicotine into the body over a period of time. The drug is available in the form of gum, lozenges, and patches. It is designed to reduce cravings and withdrawal symptoms associated with quitting smoking. It is also used to help reduce the risk of relapse.
Nicotine Polacrilex is available without a prescription and is widely available in pharmacies, supermarkets, and online. It is often used in combination with other smoking cessation therapies such as counseling and support groups.
Some companies in the Nicotine Polacrilex market include GlaxoSmithKline, Johnson & Johnson, Pfizer, Novartis, and Perrigo. Show Less Read more